Terpenes arrest parasite development and inhibit biosynthesis of isoprenoids in Plasmodium falciparum

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 7, 2004, Pages 2502-2509

  Goulart, Herbert Rodrigues ^a   Kimura, Emília A ^a   Peres, Valnice J ^a   Couto, Alicia S ^b   Duarte, Fulgencio A Aquino ^a   Katzin, Alejandro M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; FARNESOL; FARNESYLTHIOSALICYLIC ACID; FOSMIDOMYCIN; ISOPRENOID; LIMONENE; LINALOOL; NEROLIDOL; TERPENE DERIVATIVE;

ANTIMALARIAL ACTIVITY; ARTICLE; BIOSYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; MALARIA; MALARIA CONTROL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARASITE DEVELOPMENT; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SCHIZONT; STEROIDOGENESIS; TROPHOZOITE;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; DEPRESSION, CHEMICAL; DOLICHOL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ERYTHROCYTES; FARNESOL; LIPID METABOLISM; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PRECIPITIN TESTS; SALICYLIC ACIDS; TERPENES; UBIQUINONE;

EID: 3042533925     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.7.2502-2509.2004     Document Type: Article

References (42)

1. Braun-Breton, C., M. Jendoubi, E. Brunet, L. Perrin, J. Scaife, and L. Pereira da Silva. 1986. In vivo time course of synthesis and processing of major schizont membrane polypeptides in Plasmodium falciparum. Mol. Biochem. Parasitol. 20:33-43.
2. Chojnacki, T., and G. Dallner. 1988. The biological role of dolichol. Biochem. J. 251:1-9.
3. Correll, C. C., L. Ng, and P. A. Edwards. 1994. Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem. 269:17390-17393.
4. Couto, A. S., E. A. Kimura, V. J. Peres, M. L. Uhrig, and A. M. Katzin. 1999. Active isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units. Biochem. J. 341:629-637.
5. Cowan, M. M. 1999. Plant products as antimicrobial agents. Clin. Microbiol. Rev. 12:564-582.
6. Crowell, P. L. 1999. Prevention and therapy of cancer by dietary monoterpenes. J. Nutr. 129:775S-778S.
7. de Macedo, C. S., M. L. Uhrig, E. A. Kimura, and A. M. Katzin. 2002. Characterization of the isoprenoid chain of coenzyme Q in Plasmodium falciparum. FEMS Microbiol. Lett. 207:13-20.
8. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
9. Dewick, P. M. 1999. The biosynthesis of C5-C25 terpenoid compounds. Nat. Prod. Rep. 16:97-130.
10. Dewick, P. M. 2002. The biosynthesis of C5-C25 terpenoid compounds. Nat. Prod. Rep. 19:181-222.
11. do Socorro, S. R. M. S., R. R. Mendonca-Filho, H. R. Bizzo, I. de Almeida Rodrigues, R. M. Soares, T. Souto-Padron, C. S. Alviano, and A. H. Lopes. 2003. Antileishmanial activity of a linalool-rich essential oil from Croton cajucara. Antimicrob. Agents Chemother. 47:1895-1901.
12. Duker-Eshun, G., J. W. Jaroszewski, W. A. Asomaning, F. Oppong-Boachie, C. E. Olsen, and S. B. Christensen. 2002. Antiplasmodial activity of labdanes from Aframomum latifolium and Aframomum sceptrum. Planta Med. 68:642-644.
13. Eckstein-Ludwig, U., R. J. Webb, I. D. Van Goethem, J. M. East, A. G. Lee, M. Kimura, P. M. O'Neill, P. G. Bray, S. A. Ward, and S. Krishna. 2003. Artemisinins target the SERCA of Plasmodium falciparum. Nature 424:957-961.
14. Egozi, Y., B. Weisz, M. Gana-Weisz, G. Ben-Baruch, and Y. Kloog. 1999. Growth inhibition of ras-dependent tumors in nude mice by a potent rasdislodging antagonist. Int J. Cancer. 80:911-918.
15. Elad, G., A. Paz, R. Haklai, D. Marciano, A. Cox, and Y. Kloog. 1999. Targeting of K-Ras 4B by S-trans, trans-farnesyl thiosalicylic acid. Biochim. Biophys. Acta 1452:228-242.
16. Gana-Weisz, M., J. Halaschek-Wiener, B. Jansen, G. Elad, R. Haklai, and Y. Kloog. 2002. The Ras inhibitor S-trans, trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance. Clin. Cancer Res. 8:555-565.
17. Gardner, M. J., N. Hall, E. Fung, O. White, M. Berriman, R. W. Hyman, J. M. Carlton, A. Pain, K. E. Nelson, S. Bowman, I. T. Paulsen, K. James, J. A. Eisen, K. Rutherford, S. L. Salzberg, A. Craig, S. Kyes, M. S. Chan, V. Nene, S. J. Shallom, B. Suh, J. Peterson, S. Angiuoli, M. Pertea, J. Allen, J. Selengut, D. Haft, M. W. Mather, A. B. Vaidya, D. M. Martin, A. H. Fairlamb, M. J. Fraunholz, D. S. Roos, S. A. Ralph, G. I. McFadden, L. M. Cummings, G. M. Subramanian, C. Mungall, J. C. Venter, D. J. Carucci, S. L. Hoffman, C. Newbold, R. W. Davis, C. M. Fraser, and B. Barrell. 2002. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419:498-511.
18. Goldstein, J. L., and M. S. Brown. 1990. Regulation of the mevalonate pathway. Nature 343:425-430.
19. Haklai, R., M. G. Weisz, G. Elad, A. Paz, D. Marciano, Y. Egozi, G. Ben-Baruch, and Y. Kloog. 1998. Dislodgment and accelerated degradation of Ras. Biochemistry 37:1306-1314.
20. Holstein, S. A., and R. J. Hohl. 2003. Monoterpene regulation of Ras and Ras-related protein expression. J. Lipid Res. 44:1209-1215.
21. Jomaa, H., J. Wiesner, S. Sanderbrand, B. Altincicek, C. Weidemeyer, M. Hintz, L. Turbachova, M. Eberl, J. Zeidler, H. K. Lichtenthaler, D. Soldati, and E. Beck. 1999. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 285:1573-1576.
22. Kawata, S., T. Nagase, E. Yamasaki, H. Ishiguro, and Y. Matsuzawa. 1994. Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2). Br. J. Cancer. 69:1015-1020.
23. Kellogg, B. A., and C. D. Poulter. 1997. Chain elongation in the isoprenoid biosynthetic pathway. Curr. Opin. Chem. Biol. 1:570-578.
24. Kessler, S. W. 1975. Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A. J. Immunol. 115:1617-1624.
25. Kimura, E. A., A. S. Couto, V. J. Peres, O. L. Casal, and A. M. Katzin. 1996. N-linked glycoproteins are related to schizogony of the intraerythrocytic stage in Plasmodium falciparum. J. Biol. Chem. 271:14452-14461.
26. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
27. Lopes, N. P., M. J. Kato, E. H. Andrade, J. G. Maia, M. Yoshida, A. R. Planchart, and A. M. Katzin. 1999. Antimalarial use of volatile oil from leaves of Virola surinamensis (Rol.) Warb. by Waiapi Amazon Indians. J. Ethnopharmacol. 67:313-319.
28. Marciano, D., G. Ben-Baruch, M. Marom, Y. Egozi, R. Haklai, and Y. Kloog. 1995. Farnesyl derivatives of rigid carboxylic acids-inhibitors of ras-dependent cell growth. J. Med. Chem. 38:1267-1272.
29. Moura, I. C., G. Wunderlich, M. L. Uhrig, A. S. Couto, V. J. Peres, A. M. Katzin, and E. A. Kimura. 2001. Limonene arrests parasite development and inhibits isoprenylation of proteins in Plasmodium falciparum. Antimicrob. Agents Chemother. 45:2553-2558.
30. Palmer, D. N., D. R. Husbands, P. J. Winter, J. W. Blunt, and R. D. Jolly. 1986. Ceroid lipofuscinosis in sheep. I. Bis(monoacylglycerol)phosphate, dolichol, ubiquinone, phospholipids, fatty acids, and fluorescence in liver lipopigment lipids. J. Biol. Chem. 261:1766-1772.
31. Pasvol, G., R. J. Wilson, M. E. Smalley, and J. Brown. 1978. Separation of viable schizont-infected red cells of Plasmodium falciparum from human blood. Ann. Trop. Med. Parasitol. 72:87-88.
32. Pattnaik, S., V. R. Subramanyam, M. Bapaji, and C. R. Kole. 1997. Antibacterial and antifungal activity of aromatic constituents of essential oils. Microbios 89:39-46.
33. Pouter, C. D., P. L. Wiggins, and T. L. Plummer. 1981. Isolation and assay of dolichol and dolichyl phosphate. J. Org. Chem. 46:1532-1533.
34. Rohmer, M. 1999. The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants. Nat. Prod. Rep. 16:565-574.
35. Sacchettini, J. C., and C. D. Poulter. 1997. Creating isoprenoid diversity. Science 277:1788-1789.
36. Shi, W., and M. N. Gould. 1995. Induction of differentiation in neuro-2A cells by the monoterpene perillyl alcohol. Cancer Lett. 95:1-6.
37. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-67.
38. Utzinger, J., M. Tanner, and B. H. Singer. 2001. The Internet: a valuable tool for Roll Back Malaria. Trends Parasitol. 17:159-161.
39. Vial, H. J. 2000. Isoprenoid biosynthesis and drug targeting in the Apicomplexa. Parasitol. Today 16:140-141.
40. Vial, H. J., M. L. Ancelin, J. R. Philippot, and M. J. Thuet. 1990. Biosynthesis and dynamics of lipids in Plasmodium-infected mature mammalian erythrocytes. Blood Cells 16:531-561.
41. Wang, K. C., and S. Ohnuma. 2000. Isoprenyl diphosphate synthases. Biochim. Biophys. Acta 1529:33-48.
42. Wiesner, J., D. Henschker, D. B. Hutchinson, E. Beck, and H. Jomaa. 2002. In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin. Antimicrob. Agents Chemother. 46:2889-2894.